Statin safety: myths and reality
More frequent statin prescription, to achieve lower target low-density lipoprotein levels, as well as statin dose increase, is associated with inevitable raise in adverse event rates. The article compares statin benefits and the risk of adverse liver, muscle, brain, and kidney effects.
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2007-04-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1212 |
| id |
doaj-ed87fb79f43842fb8c7f18a158210fad |
|---|---|
| record_format |
Article |
| spelling |
doaj-ed87fb79f43842fb8c7f18a158210fad2021-07-28T13:50:44Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252007-04-0162105112924Statin safety: myths and realityZh. D. Kobalava0S. V. Villevalde1E. K. Shavarova2Russian University of People's Friendship, MoscowRussian University of People's Friendship, MoscowRussian University of People's Friendship, MoscowMore frequent statin prescription, to achieve lower target low-density lipoprotein levels, as well as statin dose increase, is associated with inevitable raise in adverse event rates. The article compares statin benefits and the risk of adverse liver, muscle, brain, and kidney effects.https://cardiovascular.elpub.ru/jour/article/view/1212dyslipoproteinemiastatinsadverse effects |
| collection |
DOAJ |
| language |
Russian |
| format |
Article |
| sources |
DOAJ |
| author |
Zh. D. Kobalava S. V. Villevalde E. K. Shavarova |
| spellingShingle |
Zh. D. Kobalava S. V. Villevalde E. K. Shavarova Statin safety: myths and reality Кардиоваскулярная терапия и профилактика dyslipoproteinemia statins adverse effects |
| author_facet |
Zh. D. Kobalava S. V. Villevalde E. K. Shavarova |
| author_sort |
Zh. D. Kobalava |
| title |
Statin safety: myths and reality |
| title_short |
Statin safety: myths and reality |
| title_full |
Statin safety: myths and reality |
| title_fullStr |
Statin safety: myths and reality |
| title_full_unstemmed |
Statin safety: myths and reality |
| title_sort |
statin safety: myths and reality |
| publisher |
«SILICEA-POLIGRAF» LLC |
| series |
Кардиоваскулярная терапия и профилактика |
| issn |
1728-8800 2619-0125 |
| publishDate |
2007-04-01 |
| description |
More frequent statin prescription, to achieve lower target low-density lipoprotein levels, as well as statin dose increase, is associated with inevitable raise in adverse event rates. The article compares statin benefits and the risk of adverse liver, muscle, brain, and kidney effects. |
| topic |
dyslipoproteinemia statins adverse effects |
| url |
https://cardiovascular.elpub.ru/jour/article/view/1212 |
| work_keys_str_mv |
AT zhdkobalava statinsafetymythsandreality AT svvillevalde statinsafetymythsandreality AT ekshavarova statinsafetymythsandreality |
| _version_ |
1721271404518703104 |